Publications by authors named "Yangsha Li"

Claim this Profile
D
Design and synthesis of CDK9/EZH2 dual-target inhibitors to achieve synergistic antitumor effects.
Lina Tian, Jian Xiao, Yanping Zeng, Yangsha Li, Aihuan Wei

Eur J Med Chem· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Corrigendum to "Discovery of 2,4-Quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations"[Eur. J. Med. Chem. 287 (2025) 117293].
Yanping Zeng, Jian Xiao, Li Shi, Yangsha Li, Yuanxin Xu

Eur J Med Chem· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of 2,4-quinazolinedione derivatives as LC3B recruiters in the facilitation of protein complex degradations.
Yanping Zeng, Jian Xiao, Li Shi, Yangsha Li, Yuanxin Xu

Eur J Med Chem· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BET inhibitor and CDK4/6 inhibitor synergistically inhibit breast cancer by suppressing BRD4 stability and DNA damage repair.
Shuaishuai Chi, Fan Wei, Yangsha Li, Lei Yu, Chuyao Ma

Transl Oncol· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the protective effect of ShengMai-Yin and Ganmaidazao decoction combination against type 2 diabetes mellitus with nonalcoholic fatty liver disease by network pharmacology and validation in KKAy mice.
Senlin Li, Ying Qian, Rui Xie, Yangsha Li, Zhao Jia, Lingling Tuo, Jue Liu

J Ethnopharmacol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis